Bohm Lee

Ms. Bohm Lee

Korea University
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
JLJinyoung Lee
Jinyoung Lee
JSJung Eun Shin
Jung Eun Shin
BLBohm Lee
Bohm Lee
HKHyemin Kim
Hyemin Kim
YJYewon Jeon
Yewon Jeon
YCYongcheol Cho
Yongcheol Cho
Significance: This work presents a concept for promoting the neuronal regenerative potential by engineering the expression of a stem cell marker, Prom1 . We identify Prom1 as a developmentally down-regulated neuronal intrinsic factor of axon regeneration. Replenishing Prom1 expression amplifies the axonal regenerative potential by transcriptionally inhibiting cholesterol metabolism via Smad-dependent signaling. We provide evidence that a reduction in cholesterol synthesis empowers neuronal regrowth capacity. This work suggests that Food and Drug Administration-approved cholesterol-lowering drugs are potential candidates for neuroregenerative medicine.

29 January 2022 in Journal of Biological Chemistry
Verified
Journal Article
Open access
BLBohm Lee
Bohm Lee
YOYeonsoo Oh
Yeonsoo Oh
ECEunhye Cho
Eunhye Cho
ADAaron DiAntonio
Aaron DiAntonio
VCValeria Cavalli
Valeria Cavalli
YCYongcheol Cho
Yongcheol Cho
The dual leucine zipper kinase (DLK) is a key regulator of axon regeneration and degeneration in response to neuronal injury; however, regulatory mechanisms of the DLK function via its interacting proteins are largely unknown. To better understand the molecular mechanism of DLK function, we performed yeast two-hybrid screening analysis and identified FK506-binding protein-like (FKBPL, also known as WAF-1/CIP1 stabilizing protein 39) as a DLK-binding protein. FKBPL binds to the kinase domain of DLK and inhibits its kinase activity. In addition, FKBPL induces DLK protein degradation through ubiquitin-dependent pathways. We further assessed other members in the FKBP protein family and found that FK506-binding protein 8 (FKBP8) also induced DLK degradation. We identified the lysine 271 residue in the kinase domain as a major site of DLK ubiquitination and SUMO3 conjugation and was thus responsible for regulating FKBP8-mediated proteasomal degradation that was inhibited by the substitution of the lysine 271 to arginine. FKBP8-mediated degradation of DLK is mediated by autophagy pathway because knockdown of Atg5 inhibited DLK destabilization. We show that in vivo overexpression of FKBP8 delayed the progression of axon degeneration and suppressed neuronal death after axotomy in sciatic and optic nerves. Taken together, this study identified FKBPL and FKBP8 as novel DLK-interacting proteins that regulate DLK stability via the ubiquitin-proteasome and lysosomal protein degradation pathways.

Verified
Journal Article
Open access
PDF file
BLBohm Lee
Bohm Lee
YCYongcheol Cho
Yongcheol Cho
Neurons are structurally unique and have dendrites and axons that are vulnerable to injury. Some neurons in the peripheral nervous system (PNS) can regenerate their axons after injuries. However, most neurons in the central nervous system (CNS) fail to do so, resulting in irreversible neurological disorders. To understand the mechanisms of axon regeneration, various experimental models have been utilized in vivo and in vitro. Here, we collate the key experimental models that revealed the important mechanisms regulating axon regeneration and degeneration in different systems. We also discuss the advantages of experimenting with the rodent model, considering the application of these findings in understanding human diseases and for developing therapeutic methods.

20 August 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
BLBohm Lee
Bohm Lee
YOYeonsoo Oh
Yeonsoo Oh
ECEunhye Cho
Eunhye Cho
ADAaron DiAntonio
Aaron DiAntonio
VCValeria Cavalli
Valeria Cavalli
YCYongcheol Cho
Yongcheol Cho
DLK is a key regulator of axon regeneration and degeneration in response to neuronal injury. To understand the molecular mechanisms controlling the DLK function, we performed yeast two-hybrid screening analysis and identified FKBPL as a DLK-binding protein that bound to the kinase domain and inhibited the kinase enzymatic activity of DLK. FKBPL regulated DLK stability through ubiquitin-dependent DLK degradation. We tested other members in the FKBP protein family and found that FKBP8 also induced DLK degradation as FKBPL did. We found that Lysine 271 residue in the kinase domain of DLK was a major site of ubiquitination and SUMO3-conjugation and responsible for FKBP8-mediated degradation. In vivo overexpression of FKBP8 delayed progression of axon degeneration and neuronal death following axotomy in sciatic and optic nerves, respectively, although axon regeneration efficiency was not enhanced. This research identified FKBPL and FKBP8 as new DLK-interacting proteins that regulated DLK stability by MG-132 or bafilomycin A1-sensitive protein degradation.